BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2409873)

  • 1. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ; Charache S; Nora R; Boyer SH
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract]   [Full Text] [Related]  

  • 2. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS
    Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and hemoglobin F synthesis in sickle cell disease.
    Dover GJ; Charache S
    Ann N Y Acad Sci; 1989; 565():222-7. PubMed ID: 2476061
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
    Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
    Nienhuis AW; Ley TJ; Humphries RK; Young NS; Dover G
    Ann N Y Acad Sci; 1985; 445():198-211. PubMed ID: 2409872
    [No Abstract]   [Full Text] [Related]  

  • 8. 5-Azacytidine and fetal hemoglobin.
    Heller P; DeSimone J
    Am J Hematol; 1984; 17(4):439-47. PubMed ID: 6208778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F cell production.
    Dover GJ; Humphries RK; Moore JG; Ley TJ; Young NS; Charache S; Nienhuis AW
    Blood; 1986 Mar; 67(3):735-8. PubMed ID: 2418898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    J Clin Invest; 1984 Aug; 74(2):652-6. PubMed ID: 6205021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ; Nienhuis AW
    Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of hydroxyurea on fetal hemoglobin production in vitro.
    Miller BA; Platt O; Hope S; Dover G; Nathan DG
    Blood; 1987 Dec; 70(6):1824-9. PubMed ID: 2445401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of variable doses of 5-azacytidine on fetal hemoglobin production in sickle cell anemia.
    Dover GJ; Charache SH
    Prog Clin Biol Res; 1984; 165():73-83. PubMed ID: 6209731
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
    Humphries RK; Dover G; Young NS; Moore JG; Charache S; Ley T; Nienhuis AW
    J Clin Invest; 1985 Feb; 75(2):547-57. PubMed ID: 2579100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic manipulation of fetal hemoglobin. Update on clinical trials with hydroxyurea.
    Dover GJ
    Ann N Y Acad Sci; 1990; 612():184-90. PubMed ID: 1705407
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors.
    Cao H
    Hematology; 2004 Jun; 9(3):223-33. PubMed ID: 15204104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.